Recent Advances in Antiviral Natural Products, 2nd Edition

Dear Colleagues,

The rise of infectious diseases caused by emerging and re-emerging viruses represents a serious threat to global health. While significant progress has been made in the development of antiviral drugs, many agents remain underutilized due to high toxicity, limited efficacy, or the rapid emergence of resistance. One promising strategy to overcome these limitations is the exploration of natural extracts and products, which often display lower toxicity and a reduced likelihood of resistance development. Among these, antimicrobial peptides (AMPs) have emerged as particularly attractive candidates due to their broad-spectrum antiviral activity and multifunctional roles in host defense.

This Special Issue aims to gather original research articles and comprehensive reviews that highlight recent advances in the development of natural antiviral products, including antimicrobial peptides, as well as other bioactive compounds with potential therapeutic applications. We particularly welcome contributions that explore mechanisms of action, drug delivery strategies, and translational applications to prevent or control viral infections.

We invite authors to submit original manuscripts addressing all aspects of this topic, contributing to the advancement of natural antiviral strategies and the preparedness for future viral outbreaks.

Prof. Dr. Massimiliano Galdiero
Dr. Carla Zannella
Dr. Annalisa Chianese
Dr. Rosa Giugliano
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.